Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
7
pubmed:dateCreated
2003-9-25
pubmed:abstractText
Estrogen is one of the crucial hormones participating in the proliferation and carcinogenesis of the prostate glands. Genetic polymorphisms in the estrogen metabolism pathway might be involved in the risk of prostate carcinoma development. The authors evaluated the association between genetic polymorphisms in estrogen-related enzymes and receptors and the risk of developing familial prostate carcinoma.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Oct
pubmed:issn
0008-543X
pubmed:author
pubmed:copyrightInfo
Copyright 2003 American Cancer Society.DOI 10.1002/cncr.11639
pubmed:issnType
Print
pubmed:day
1
pubmed:volume
98
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1411-6
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:14508827-Adult, pubmed-meshheading:14508827-Age Distribution, pubmed-meshheading:14508827-Aged, pubmed-meshheading:14508827-Aromatase, pubmed-meshheading:14508827-Carcinoma, pubmed-meshheading:14508827-Case-Control Studies, pubmed-meshheading:14508827-Catechol O-Methyltransferase, pubmed-meshheading:14508827-Chi-Square Distribution, pubmed-meshheading:14508827-Cohort Studies, pubmed-meshheading:14508827-Estrogen Receptor alpha, pubmed-meshheading:14508827-Genetic Predisposition to Disease, pubmed-meshheading:14508827-Humans, pubmed-meshheading:14508827-Incidence, pubmed-meshheading:14508827-Japan, pubmed-meshheading:14508827-Male, pubmed-meshheading:14508827-Middle Aged, pubmed-meshheading:14508827-Neoplasm Staging, pubmed-meshheading:14508827-Odds Ratio, pubmed-meshheading:14508827-Polymorphism, Genetic, pubmed-meshheading:14508827-Probability, pubmed-meshheading:14508827-Prostatic Neoplasms, pubmed-meshheading:14508827-Receptors, Estrogen, pubmed-meshheading:14508827-Risk Assessment
pubmed:year
2003
pubmed:articleTitle
Genetic polymorphisms of estrogen receptor alpha, CYP19, catechol-O-methyltransferase are associated with familial prostate carcinoma risk in a Japanese population.
pubmed:affiliation
Department of Urology, Gunma University School of Medicine, Maebashi, Japan.
pubmed:publicationType
Journal Article, Comparative Study, Research Support, Non-U.S. Gov't